Recent Updates
Recently added Catalysts
QDEL Positive Sentiment

Faster Cardiac Answers with High‑Sensitivity Troponin QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 56 of its Science Bytes podcast, featuring Dr....

Thursday, February 19, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: QuidelOrtho Corporation has launched episode 56 of its Science Bytes podcast, featuring Dr. Lindy Carlstrom. The episode discusses the impact of high-sensitivity troponin on early cardiac diagnosis and its role in enhancing emergency department efficiency. This advancement is expected to significantly improve patient care in acute settings.
Price reaction · baseline $24.16 (2026-02-18 close) · hit after-hours · clean, no other QDEL news in the window
day 0 close · peak
-2.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • High-sensitivity troponin is enhancing cardiac diagnosis.
  • The podcast features expert insights from Dr. Lindy Carlstrom.
  • Improves efficiency in emergency departments.

Full Press Release Details

SAN DIEGO , Feb. 19, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL ), a global leader of in vitro diagnostics, has released episode 56 of its Science Bytes podcast, featuring Dr. Lindy Carlstrom, Global Medical Affairs Manager for Acute Care. In this episode, Carlstrom and host Josh Casey discuss how high-sensitivity troponin (hs troponin) is transforming early cardiac diagnosis and improving emergency department efficiency.
Key Insights

Frequently Asked Questions

What is the focus of episode 56 of Science Bytes?

Episode 56 focuses on high-sensitivity troponin and its impact on cardiac diagnosis.

Who features in the latest Science Bytes podcast?

Dr. Lindy Carlstrom is featured in the latest episode discussing cardiac diagnosis.

How does high-sensitivity troponin improve emergency care?

High-sensitivity troponin enhances early cardiac diagnosis and boosts emergency department efficiency.

ShareAdd on Google
Tags: QDEL Viatris Investor Conferences Healthcare QuidelOrtho cardiac diagnosis emergency department in vitro diagnostics
Last updated: Feb 19, 2026

Biotech snapshot

Cash runway
$123M liquidity · $7M/mo burn
~17 mo
Low dilution risk